🇺🇸 FDA
Patent

US 11602568

Engineered B lymphocytes and compositions having micro-RNA and methods for making and using them

granted A61KA61K2239/31A61K2239/38

Quick answer

US patent 11602568 (Engineered B lymphocytes and compositions having micro-RNA and methods for making and using them) held by The Regents of the University of California expires Mon Mar 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Mar 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K2239/31, A61K2239/38, A61K2239/49, A61K31/7105